Jasper Therapeutics, Inc. logo

Jasper Therapeutics, Inc.

JSPRNASDAQ

Jasper Therapeutics, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Ronald Martell, with a market cap of $49.5M. As of Q3 2025, 72% of shares are held by 60 institutional investors, with Velan Capital Investment Management LP as the largest holder at 9.56%.

President and CEO of Jasper Therapeutics, Inc.Ronald Martell
Market Cap$49.5M
Biotechnology
Healthcare
Employees45.0
Country
United States of America

Overview

Overview of institutional ownership in JSPR as of Q3 2025 with a market cap of $66.5M

All Institutions

Institutions
60
Value Held
$47.8M
Shares Held
20.2M
Avg Position
$796.9K
Median Position
$97.9K

Hedge Funds

Hedge Funds
15
Value Held
$19.3M
Shares Held
8.1M
Avg Position
$1.3M
Median Position
$868.6K

Ownership Breakdown

Institutional (non-HF): 42.95%Institutional (non-HF)Hedge Funds: 29.00%Hedge FundsRetail & Other: 28.05%Retail & Other
Institutional (non-HF)
42.95%
$28.5M
Hedge Funds
29.0%
$19.3M
Retail & Other
28.05%
$18.6M

Based on market cap of $66.5M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.

Biggest Investors

Institutions with the largest positions in JSPR as of Q3 2025

InstitutionPosition Value
$6.2M
5.83% of portfolio
Soleus Capital Management, L.P. logo
Soleus Capital Management, L.P.
Hedge FundLong/Short
$3.6M
0.19% of portfolio
$3.3M
1.67% of portfolio
K
KINGDON CAPITAL MANAGEMENT, L.L.C.
Hedge FundLong/Short
$3.2M
0.49% of portfolio
$2.6M
0.15% of portfolio
$2.5M
0.06% of portfolio
Woodline Partners LP logo
Woodline Partners LP
Hedge FundLong/Short
$2.5M
0.01% of portfolio
$2.5M
0.00% of portfolio
$2.4M
0.00% of portfolio
Propel Bio Management, LLC logo
Propel Bio Management, LLC
Hedge FundSector
$2.4M
2.45% of portfolio

Net Capital Flow

Institutional buying and selling activity for JSPR in Q3 2025

Traded
+$13.6M
Buyers
32
Sellers
35
Total Bought
+$23.6M
Total Sold
$10.0M
Avg Position
$613.0K

Biggest Buyers

InstitutionNet Bought
+$3.3M
+1.4M shares
+$2.9M
+1.2M shares
Woodline Partners LP logo
Woodline Partners LP
Hedge FundLong/Short
+$2.5M
+1.0M shares
Propel Bio Management, LLC logo
Propel Bio Management, LLC
Hedge FundSector
+$2.4M
+1.0M shares
K
KINGDON CAPITAL MANAGEMENT, L.L.C.
Hedge FundLong/Short
+$1.5M
+640.1K shares
+$1.5M
+614.8K shares
+$1.4M
+609.1K shares
+$1.3M
+555.6K shares
+$1.1M
+442.6K shares
+$971.6K
+408.2K shares

Biggest Sellers

InstitutionNet Sold
$3.3M
590.0K shares
$3.0M
534.7K shares
UBS Group AG logo
UBS Group AG
Institution
$897.1K
376.9K shares
$737.6K
132.9K shares
$530.5K
222.9K shares
$281.3K
50.7K shares
AQR CAPITAL MANAGEMENT LLC logo
AQR CAPITAL MANAGEMENT LLC
Hedge FundMulti-Strategy
$197.2K
35.5K shares
X
XTX Topco Ltd
Institution
$151.8K
27.3K shares
$147.9K
26.7K shares
$110.3K
46.3K shares

Entry and Exit Activity

Institutions that initiated new positions or completely exited JSPR in Q3 2025

New Positions
8
New Value
$4.9M
Exited Positions
18
Exited Value
$8.2M

New Positions

InstitutionPosition Value
$3.3M
1.4M shares
ARMISTICE CAPITAL, LLC logo
ARMISTICE CAPITAL, LLC
Hedge FundLong/Short
$828.2K
348.0K shares
K
Knott David M Jr
Institution
$407.9K
171.4K shares
R
READYSTATE ASSET MANAGEMENT LP
Hedge FundMulti-Strategy
$234.3K
98.4K shares
$49.9K
21.0K shares
$48.1K
20.2K shares
$124.0
50.0 shares
$14.0
6.0 shares

Exited Positions

InstitutionPrevious Position
$3.3M
590.0K shares
$3.0M
534.7K shares
$737.6K
132.9K shares
$281.3K
50.7K shares
AQR CAPITAL MANAGEMENT LLC logo
AQR CAPITAL MANAGEMENT LLC
Hedge FundMulti-Strategy
$197.2K
35.5K shares
X
XTX Topco Ltd
Institution
$151.8K
27.3K shares
$147.9K
26.7K shares
$101.9K
18.4K shares
$83.4K
15.0K shares
H
$82.1K
14.8K shares

Options Activity

Institutions with the largest Call and Put options positions in JSPR as of Q3 2025

Call Positions
2
Call Value
$168.0K
Put Positions
2
Put Value
$103.1K

Call Positions

InstitutionPosition Value
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$105.9K
445.0 contracts
$62.1K
261.0 contracts

Put Positions

InstitutionPosition Value
$61.6K
259.0 contracts
CITADEL ADVISORS LLC logo
CITADEL ADVISORS LLC
Hedge FundMulti-Strategy
$41.4K
174.0 contracts

Most Committed Institutions

Institutions with JSPR as the highest % of their portfolio as of Q3 2025

InstitutionPortfolio Weight
5.83%
$6.2M
L
Lion Point Capital, LP
Hedge FundEvent Driven
5.39%
$948.6K
3.97%
$2.2M
Propel Bio Management, LLC logo
Propel Bio Management, LLC
Hedge FundSector
2.45%
$2.4M
1.67%
$3.3M
K
KINGDON CAPITAL MANAGEMENT, L.L.C.
Hedge FundLong/Short
0.49%
$3.2M
0.36%
$1.5M
Soleus Capital Management, L.P. logo
Soleus Capital Management, L.P.
Hedge FundLong/Short
0.19%
$3.6M
K
Knott David M Jr
Institution
0.17%
$407.9K
0.15%
$2.6M

Hedge Fund Spotlight

Discover hedge funds investing in JSPR

S
Squarepoint Ops LLC
Hedge FundQuant
Portfolio ManagerMichael Gottlieb
Portfolio Value
$46.9B
Positions
2,529
Last Reported
Q3 2025
AddressNew York, NY
Sector Allocation
Technology: 22.10%TechnologyETF: 14.00%ETFConsumer Cyclical: 11.90%Consumer CyclicalHealthcare: 9.80%HealthcareIndustrials: 9.50%IndustrialsFinancial Services: 9.30%Financial ServicesConsumer Defensive: 5.80%Communication Services: 5.40%Energy: 3.20%Utilities: 2.70%Basic Materials: 2.30%Real Estate: 1.10%
Jasper Therapeutics, Inc. logo

Position in Jasper Therapeutics, Inc.

Market Value
$33.2K
Shares Held
14.0K
Portfolio Weight
0.00%
Owned Since
2025-Q2
Top HoldingSectorMarket ValueWeight
ETF
ETF
$5.5B11.75%
2
Amazon logo
Amazon
AMZN
Specialty Retail
Consumer Cyclical
$983.1M2.10%
3
Nvidia logo
Nvidia
NVDA
Semiconductors
Technology
$935.8M2.00%

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.